Chemical activators of C6orf174 can play a significant role in its functional activation through various biochemical pathways. Forskolin is one such activator, which directly stimulates adenylate cyclase leading to an increase in cyclic AMP (cAMP) levels. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate C6orf174, leading to its activation. Similarly, 8-Bromo-cAMP, a cAMP analog, activates PKA that may also phosphorylate and activate C6orf174. Ionomycin acts as a calcium ionophore that raises intracellular calcium levels, which, in turn, can activate calcium-dependent kinases. These kinases have the capacity to phosphorylate C6orf174, thereby activating it. Another compound, A23187, also elevates intracellular calcium, further amplifying the potential for kinase-mediated activation of C6orf174.
Additionally, Thapsigargin, which inhibits the SERCA pump, leads to an increase in cytosolic calcium levels, potentially activating kinases that phosphorylate C6orf174. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), a kinase that can target and phosphorylate C6orf174. Anisomycin, a stress-activated protein kinase activator, can facilitate the phosphorylation of C6orf174 by these stress-related kinases. Zaprinast, by inhibiting phosphodiesterases, raises cGMP levels, which can activate protein kinase G (PKG), potentially resulting in phosphorylation and activation of C6orf174. Spermine NONOate, through its release of nitric oxide, increases cGMP levels and similarly can lead to PKG-mediated activation of C6orf174. Bisindolylmaleimide I, under particular conditions, can activate PKC, which might then lead to the phosphorylation and consequent activation of C6orf174. Okadaic Acid, a phosphatase inhibitor, can maintain C6orf174 in an active phosphorylated state by inhibiting the dephosphorylating enzymes. Lastly, H-89, though primarily known as a PKA inhibitor, can have a regulatory role and might lead to compensatory activation of pathways that include C6orf174, thereby contributing to its activation. Each of these chemicals, by targeting specific cellular pathways and enzymes, ensures the activation of C6orf174 through a cascade of phosphorylation events.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
cAMP analog that activates PKA, potentially leading to phosphorylation and activation of C6orf174. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Calcium ionophore that raises intracellular calcium, which may activate kinases that phosphorylate and activate C6orf174. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, potentially activating kinases that can phosphorylate and activate C6orf174. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Inhibits the SERCA pump, increasing calcium levels and potentially leading to activation of kinases that target C6orf174. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates PKC, which may phosphorylate and activate C6orf174. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Activates stress-activated protein kinases that could phosphorylate and activate C6orf174. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Inhibits phosphodiesterases, raising cGMP which could activate PKG that phosphorylates and activates C6orf174. | ||||||
Spermine NONOate | 136587-13-8 | sc-202816 sc-202816A | 5 mg 25 mg | $53.00 $196.00 | 5 | |
Releases nitric oxide to increase cGMP and activate PKG, potentially leading to activation of C6orf174. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Under certain conditions can activate PKC, potentially leading to phosphorylation and activation of C6orf174. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Inhibits protein phosphatases, which could keep C6orf174 in an active state by preventing dephosphorylation. | ||||||